Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="BOUTARD, P" or (type any "bookEditor journalEditor issueEditor" and editor="BOUTARD, P")

Add to list
NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

E Clappier, S Collette, N Grardel, S Girard, L Suarez, G Brunie, S Kaltenbach, K Yakouben, F Mazingue, A Robert, et al.

(2010) LEUKEMIA. 24(12). p.2023-2031
Add to list
- Journal Article
- A1
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report

N ENTZ-WERLE, S SUCIU, JD TEN BOSCH, E VILMER, Y BERTRAND, Yves Benoit, G MARGUERITTE, E PLOUVIER, P BOUTARD, Els Vandecruys (UGent) , et al.

(2005) LEUKEMIA. 19(12). p.2072-2081
Add to list
- Journal Article
- A1
Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

H CAVÉ, S SUCIU, C PREUDHOMME, Bruce Poppe (UGent) , A ROBERT, A UYTTEBROECK, M MALET, P BOUTARD, Yves Benoit, L MAUVIEUX, et al.

(2004) BLOOD. 103(2). p.442-450
Add to list
- Conference Paper
- C3
HOX11L2 expression linked to t(5;14)(q35;q32) is not associated with poor prognosis in childhood T-ALL treated in EORTC trials 58 881 and 58 951

H CAVÉ, S SUCIU, C PREUDHOMME, Bruce Poppe (UGent) , A ROBERT, A UYTTEBROEK, M MALET, P BOUTARD, Yves Benoit, L MAUVIEUX, et al.

(2002) BLOOD. 100(11).
Add to list
- Journal Article
- A1
Treatment outcome in infant acute lymphoblastic leukemia.

A FERSTER, Yves Benoit, N FRANCOTTE, MF DRESSE, A UYTTEBROECK, E PLOUVIER, A THYSS, P LUTZ, G MARGUERITE, C BEHAR, et al.

(2000) BLOOD. 95(8). p.2729-2730

Academic Bibliography

NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951

Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report

Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

HOX11L2 expression linked to t(5;14)(q35;q32) is not associated with poor prognosis in childhood T-ALL treated in EORTC trials 58 881 and 58 951

Treatment outcome in infant acute lymphoblastic leukemia.

Contents

Support

Contact